多发性骨髓瘤FDG PET/CT判读标准(IMPeTUs):最终结果——意大利骨髓瘤PET使用标准
本研究在多中心前瞻性EMN02试验中评估IMPeTUs视觉描述标准在86例症状性多发性骨髓瘤患者211次FDG PET/CT扫描中的可重复性,五名核医学专家独立盲法中央判读。各时间点判读者间一致率均超过75%,Deauville评分可重复性高(评分4最高),结论认为IMPeTUs标准高度可重复,可作为统一PET判读的基础,前瞻性临床验证正在进行中。
要点
- IMPeTUs标准在基线、诱导后及治疗结束各时间点判读者间一致率均超过75%。
- Deauville评分高度可重复,其中评分4的可重复性最高。
- 结论认为IMPeTUs标准高度可重复,可作为统一骨髓瘤PET判读的基础。
核心结论
- IMPeTUs标准被证明高度可重复,可作为统一多发性骨髓瘤PET判读的基础。
- IMPeTUs标准的前瞻性临床验证正在进行中。
研究设计与样本
- 前瞻性纳入症状性多发性骨髓瘤患者,来自多中心试验EMN02(NCT01910987;MMY3033)。
- 纳入86例患者共211次FDG PET/CT扫描,中位年龄58岁(范围35-66岁),45%为男性。
- 15%患者为ISS III期,42%具有高危细胞遗传学。
- PET图像匿名后上传至网络平台WIDEN®,分发至五名核医学专家评审进行盲法独立中央判读。
- 采用判读者间一致百分比和Krippendorff's alpha系数评估共识,并按患者分析在不同阳性阈值(Deauville评分2、3、4、5)下测试主要参数(骨髓、局灶评分、髓外疾病)的阳性或阴性一致性。
主要发现
- 所有时间点判读一致百分比均超过75%,评估治疗后颅骨病变存在时达到100%一致。
- 在PET0、PET-AI或PET-EoT各扫描时间点或所有扫描总体分析中,使用Krippendorff's alpha系数进行一致性分析获得可比结果。
- Deauville评分被证明高度可重复,其中评分4的可重复性最高。
局限性
- IMPeTUs标准的前瞻性临床验证正在进行中。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: ᅟ: FDG PET/CT (18F-fluoro-deoxy-glucose positron emission tomography/computed tomography) is a useful tool to image multiple myeloma (MM). However, simple and reproducible reporting criteria are still lacking and there is the need for harmonization. Recently, a group of Italian nuclear medicine experts defined new visual descriptive criteria (Italian Myeloma criteria for Pet Use: IMPeTUs) to standardize FDG PET/CT evaluation in MM patients. The aim of this study was to assess IMPeTUs reproducibility on a large prospective cohort of MM patients. MATERIALS AND METHODS: Patients affected by symptomatic MM who had performed an FDG PET/CT at baseline (PET0), after induction (PET-AI), and the end of treatment (PET-EoT) were prospectively enrolled in a multicenter trial (EMN02)(NCT01910987; MMY3033). After anonymization, PET images were uploaded in the web platform WIDEN® and hence distributed to five expert nuclear medicine reviewers for a blinded independent central review according to the IMPeTUs criteria. Consensus among reviewers was measured by the percentage of agreement and the Krippendorff's alpha. Furthermore, on a patient-based analysis, the concordance among all the reviewers in terms of positivity or negativity of the FDG PET/CT scan was tested for different thresholds of positivity (Deauville score (DS 2, 3, 4, 5) for the main parameters (bone marrow, focal score, extra-medullary disease). RESULTS: Eighty-six patients (211 FDG PET/CT scans) were included in this analysis. Median patient age was 58 years (range, 35-66 years), 45% were male, 15% of them were in stage ISS (International Staging System) III, and 42% had high-risk cytogenetics. The percentage agreement was superior to 75% for all the time points, reaching 100% of agreement in assessing the presence skull lesions after therapy. Comparable results were obtained when the agreement analysis was performed using the Krippendorff's alpha coefficient, either in every single time point of scanning (PET0, PET-AI or PET-EoT) or overall for all the scans together. DS proved highly reproducible with the highest reproducibility for score 4. CONCLUSIONS: IMPeTUs criteria proved highly reproducible and could therefore be considered as a base for harmonizing PET interpretation in multiple myeloma. A prospective clinical validation of IMPeTUs criteria is underway.
引用
- Nanni C, Versari A, Chauvie S, et al. Interpretation criteria for FDG PET/CT in multiple myeloma (IMPeTUs): final results. IMPeTUs (Italian myeloma criteria for PET USe). Eur J Nucl Med Mol Imaging. 2017. PMID: 29270787. doi:10.1007/s00259-017-3909-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。